Challenges posed to the European pharmaceutical regulatory system by highly personalized medicines.

Abstract

The European pharmaceutical regulatory system has not yet been challenged by issues related to highly personalized medicines such as those to be found with active substances that affect RNA biochemistry. We review the current status of RNA-based pharmacology and present three possible case histories. The implications for the European pharmaceutical… (More)
DOI: 10.1111/bcp.12173

Topics

Cite this paper

@article{Johnston2014ChallengesPT, title={Challenges posed to the European pharmaceutical regulatory system by highly personalized medicines.}, author={John D. Johnston and Peter Feldschreiber}, journal={British journal of clinical pharmacology}, year={2014}, volume={77 3}, pages={421-6} }